Published in Circulation on May 02, 2011
Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol (2012) 2.02
Developing a risk model for in-hospital adverse events following implantable cardioverter-defibrillator implantation: a report from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol (2013) 1.58
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc (2013) 1.30
Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR. Circ Cardiovasc Qual Outcomes (2013) 0.94
Informed consent in cardiac resynchronization therapy: what should be said? Circ Cardiovasc Qual Outcomes (2011) 0.84
Adverse events following implantable cardioverter defibrillator implantation: a systematic review. J Interv Card Electrophysiol (2014) 0.81
Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data Registry. Circulation (2013) 0.78
Device therapy: risk assessment to improve patient care following cardioverter-defibrillator implantation. Nat Rev Cardiol (2011) 0.75
Internal cardioversion of persistent atrial fibrillation in implantable cardioverter defibrillator patients: the juice is not worth the squeeze. Neth Heart J (2013) 0.75
Oversensing of atrial fibrillatory waves in a subcutaneous implantable cardioverter-defibrillator. HeartRhythm Case Rep (2017) 0.75
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00
The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86
Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med (2002) 5.74
Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes (2009) 5.66
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation (2006) 5.35
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Non-evidence-based ICD implantations in the United States. JAMA (2011) 5.05
An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation (2006) 4.52
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35
Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. JAMA (2009) 4.29
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol (2006) 4.11
Evaluation of a consumer-oriented internet health care report card: the risk of quality ratings based on mortality data. JAMA (2002) 4.06
Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail (2009) 3.95
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation (2005) 3.78
Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA (2004) 3.45
Long-term prognosis of acute kidney injury after acute myocardial infarction. Arch Intern Med (2008) 3.42
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med (2012) 2.86
Pooled analysis of rofecoxib placebo-controlled clinical trial data: lessons for postmarket pharmaceutical safety surveillance. Arch Intern Med (2009) 2.80
Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA (2003) 2.77
Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation (2005) 2.69
Concordance of physician ratings with the appropriate use criteria for coronary revascularization. J Am Coll Cardiol (2011) 2.62
National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation (2004) 2.46
Patterns of weight change preceding hospitalization for heart failure. Circulation (2007) 2.45
Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation (2006) 2.40
All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of medicare patients. J Am Coll Cardiol (2009) 2.40
The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. J Am Coll Cardiol (2003) 2.34
National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes (2010) 2.33
Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol (2010) 2.26
The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia. J Hosp Med (2010) 2.20
Use of medical imaging procedures with ionizing radiation in children: a population-based study. Arch Pediatr Adolesc Med (2011) 2.12
Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol (2010) 2.07
Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med (2003) 1.89
The relation between hospital procedure volume and complications of cardioverter-defibrillator implantation from the implantable cardioverter-defibrillator registry. J Am Coll Cardiol (2010) 1.87
Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. J Am Coll Cardiol (2011) 1.85
Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation (2005) 1.83
Physician board certification and the care and outcomes of elderly patients with acute myocardial infarction. J Gen Intern Med (2006) 1.82
Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation (2006) 1.78
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm (2010) 1.74
Quality improvement efforts and hospital performance: rates of beta-blocker prescription after acute myocardial infarction. Med Care (2005) 1.73
Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes (2013) 1.72
Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J (2006) 1.69
Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol (2005) 1.69
Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals. Circulation (2007) 1.61
Trends in acute myocardial infarction in 4 US states between 1992 and 2001: clinical characteristics, quality of care, and outcomes. Circulation (2006) 1.61
Clinical characteristics and in-hospital outcome of patients with end-stage renal disease on dialysis referred for implantable cardioverter-defibrillator implantation. Heart Rhythm (2009) 1.60
Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med (2008) 1.59
Nonsteroidal antiinflammatory drugs after acute myocardial infarction. Am Heart J (2002) 1.58
National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. J Am Coll Cardiol (2009) 1.57
Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry. Arch Intern Med (2011) 1.54
Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med (2005) 1.54
Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA (2013) 1.51
Use and effectiveness of intra-aortic balloon pumps among patients undergoing high risk percutaneous coronary intervention: insights from the National Cardiovascular Data Registry. Circ Cardiovasc Qual Outcomes (2011) 1.49
Review of the ICD Registry's third year, expansion to include lead data and pediatric ICD procedures, and role for measuring performance. Heart Rhythm (2009) 1.46
Physician specialty and mortality among elderly patients hospitalized with heart failure. Am J Med (2005) 1.45
Determinants of fluoroscopy time for invasive coronary angiography and percutaneous coronary intervention: insights from the NCDR(®). Catheter Cardiovasc Interv (2013) 1.43
Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®. Pacing Clin Electrophysiol (2012) 1.40
Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol (2009) 1.40
Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: data from the NCDR ICD Registry™. J Cardiovasc Electrophysiol (2012) 1.39
The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011. Heart Rhythm (2013) 1.39
Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm (2008) 1.38
Review of the registry's first year, data collected, and future plans. Heart Rhythm (2007) 1.35
Discontinuation of antihyperglycemic therapy and clinical outcomes after acute myocardial infarction in older patients with diabetes. Circ Cardiovasc Qual Outcomes (2010) 1.35
The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med (2005) 1.32
Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm (2008) 1.32
Sex differences in cardiac catheterization after acute myocardial infarction: the role of procedure appropriateness. Ann Intern Med (2002) 1.31
Variation in hospital mortality rates for patients with acute myocardial infarction. Am J Cardiol (2010) 1.28
National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol (2013) 1.27
Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. JAMA (2013) 1.25
Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med (2012) 1.24
Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001. Circulation (2005) 1.24
The pre-hospital electrocardiogram and time to reperfusion in patients with acute myocardial infarction, 2000-2002: findings from the National Registry of Myocardial Infarction-4. J Am Coll Cardiol (2006) 1.24
Quality of care for acute myocardial infarction at urban safety-net hospitals. Health Aff (Millwood) (2007) 1.23
Income inequality and 30 day outcomes after acute myocardial infarction, heart failure, and pneumonia: retrospective cohort study. BMJ (2013) 1.23
Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy. Circulation (2009) 1.22
Door-to-drug and door-to-balloon times: where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI). Am Heart J (2006) 1.21
Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation (2009) 1.19
Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: an analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. J Am Coll Cardiol (2008) 1.19
A high risk of hospitalization following release from correctional facilities in Medicare beneficiaries: a retrospective matched cohort study, 2002 to 2010. JAMA Intern Med (2013) 1.19
Acute lead dislodgements and in-hospital mortality in patients enrolled in the national cardiovascular data registry implantable cardioverter defibrillator registry. J Am Coll Cardiol (2010) 1.18
Development of 2 registry-based risk models suitable for characterizing hospital performance on 30-day all-cause mortality rates among patients undergoing percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes (2012) 1.17
Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA (2003) 1.15
Regional variation in cardiac catheterization appropriateness and baseline risk after acute myocardial infarction. J Am Coll Cardiol (2008) 1.14
The impact of clinical trials on the use of hormone replacement therapy. A population-based study. J Gen Intern Med (2005) 1.14
Bleeding and vascular complications at the femoral access site following percutaneous coronary intervention (PCI): an evaluation of hemostasis strategies. J Invasive Cardiol (2012) 1.13
The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. Eur J Heart Fail (2010) 1.12
Hospital-level performance improvement: beta-blocker use after acute myocardial infarction. Med Care (2004) 1.10
The prognostic value of E-cadherin in gastric cancer: a meta-analysis. Int J Cancer (2012) 1.09
Recent trends in hospitalization for acute myocardial infarction. Am J Cardiol (2012) 1.08